FDA Approves FOSFOMYCIN TROMETHAMINE — Aucta Pharmaceuticals, Inc.

# FDA Approves Generic Fosfomycin Tromethamine, Expanding Treatment Options for Urinary Tract Infections Aucta Pharmaceuticals, Inc. received FDA approval for its generic formulation of fosfomycin tromethamine, an oral antibiotic used to treat uncomplicated urinary tract infections, potentially increasing competition in the market and improving patient access to this therapeutic option. The approval is expected to drive price competition and expand treatment availability as healthcare providers gain an additional supplier for this commonly prescribed infection treatment.